Synaptogenix Inc.

2.18
0.00 (0.00%)
At close: Apr 16, 2025, 3:30 PM
0.00%
Bid 2.09
Market Cap 3.03M
Revenue (ttm) n/a
Net Income (ttm) -12.77M
EPS (ttm) -10.99
PE Ratio (ttm) -0.2
Forward PE -0.33
Analyst Buy
Ask 2.25
Volume 700
Avg. Volume (20D) 8,536
Open 2.19
Previous Close 2.18
Day's Range 2.18 - 2.18
52-Week Range 1.84 - 5.38
Beta 1.30

About SNPX

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and N...

Industry Biotechnology
Sector Healthcare
IPO Date Dec 8, 2020
Employees 4
Stock Exchange NASDAQ
Ticker Symbol SNPX
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for SNPX stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 542.20% from the latest price.

Stock Forecasts
3 months ago
+19.46%
Synaptogenix shares are trading higher after the c... Unlock content with Pro Subscription